CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Adolescence presents a challenging time for type 1 diabetes management, and despite a multitude of studies aimed at increasing disease compl...
Indianapolis, Indiana, United States and 1 other location
Evaluating the adverse events and tolerance of R-5280 in Mitigating Type 1 Diabetes in Newly Diagnosed Patients...
Phase 1
Indianapolis, Indiana, United States and 1 other location
The purpose of this study is to assess the safety and pharmacokinetics (PK) of teplizumab in participants with Stage 2 type 1 diabetes who a...
Phase 4
Indianapolis, Indiana, United States and 9 other locations
The goal of this clinical trial is to test a drug known as DFMO in people with Type 1 Diabetes (T1D). The main question[s] it aims to answer...
Phase 2
Indianapolis, Indiana, United States and 5 other locations
Hepatic and Cardiovascular endpoints for patients with Type 2 Diabetes who are inadequately controlled with insulin therapy. The purpose of ...
Indianapolis, Indiana, United States and 62 other locations
preserving beta-cell function and delaying the progression of type 1 diabetes (T1D) in adolescent and adult patients. The safety of ladarixi...
Phase 3
Indianapolis, Indiana, United States and 56 other locations
Closed Loop system (HCL) in adult and pediatric patients with type 1 diabetes in the home setting. A diverse population of patients with typ...
Indianapolis, Indiana, United States and 37 other locations
control clinical trial testing two different JAK Inhibitors abrocitnib, ritlecitinib, and placebo in subjects with recent onset Stage 3 Type 1 Diabetes...
Phase 2
Indianapolis, Indiana, United States and 14 other locations
This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...
Phase 3
Avon, Indiana, United States and 173 other locations
This study compares 2 medicines for type 2 diabetes: semaglutide (new medicine) and a dummy medicine (placebo). Semaglutide will be tested t...
Phase 3
Indianapolis, Indiana, United States and 87 other locations
Clinical trials
Research sites
Resources
Legal